Overview
Formerly MAPS Public Benefit Corporation, Lykos Therapeutics is advancing MDMA-assisted therapy for PTSD through Phase 3 clinical trials and FDA regulatory review. They are a pioneer in the clinical development of psychedelic-assisted psychotherapy.
More in Psychedelics
Latest industry news
It's Finally Here: FacialDx, an AI-Powered Support Tool for Sideline Concussion Assessments
2026-06-23 · Product
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Category
🍄 Psychedelics
Location
San Jose, CA, USA
Funding
Non-profit/PBC · Grant-funded
Website
lykostherapeutics.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →